⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAGX News
Jaguar Health, Inc.
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
accessnewswire.com
JAGX
Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
accessnewswire.com
JAGX
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Reports Second Quarter 2026 Financials
accessnewswire.com
JAGX
Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
accessnewswire.com
JAGX
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
accessnewswire.com
JAGX
Hitung Mundur Peluncuran FREELANDER Timur Tengah — SUV Premium Inggris Menetapkan Tolok Ukur Global Baru untuk Parkir Pintar dengan SIVP
globenewswire.com
JAGX